Fundz

Vyne Therapeutics reported raising $300,000 in an initial SEC Form D filing, from an offering of $300,000

PUBLIC · YARWNov 18, 2022

Amount Raised

$300,000

$300,000 sold, per SEC Form D (first sale Nov 14, 2022)

Round Type

Seed

New HavenBiotechnologyHealthcareHealth CareTherapeutics

Who to call at Yarrow Bioscience, and when

A new round usually means Yarrow Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Yarrow Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Yarrow Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Yarrow Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Yarrow Bioscience

Location

New Haven, Connecticut, United States

About

Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Founded by RTW Investments, Yarrow is advancing its lead program, YB-101, which targets thyroid-stimulating hormone receptors for the treatment of Graves' disease and thyroid eye disease. The company aims to address significant unmet needs in these therapeutic areas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Yarrow Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsIgor, Chief Scientific Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Yarrow Bioscience's next move

See what Strategic adds

Yarrow Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.